-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TSTK3nNyFJ1V4homDtdPyEyLniRg/IDG5jK0NQAVNkx9ELDPRqUpyvbAt++brJdA d9IEMlPA/gtgTdrzdad3Ow== 0001209191-10-059990.txt : 20101213 0001209191-10-059990.hdr.sgml : 20101213 20101213181407 ACCESSION NUMBER: 0001209191-10-059990 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20101210 FILED AS OF DATE: 20101213 DATE AS OF CHANGE: 20101213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDO PHARMACEUTICALS HOLDINGS INC CENTRAL INDEX KEY: 0001100962 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134022871 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ENDO BOULEVARD CITY: CHADDS FORD STATE: PA ZIP: 19317 BUSINESS PHONE: 6105589800 MAIL ADDRESS: STREET 1: 100 ENDO BOULEVARD CITY: CHADDS FORD STATE: PA ZIP: 19317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIMMEL ROGER H CENTRAL INDEX KEY: 0001034272 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15989 FILM NUMBER: 101248981 MAIL ADDRESS: STREET 1: LATHAM & WATKINS STREET 2: 885 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-12-10 0 0001100962 ENDO PHARMACEUTICALS HOLDINGS INC ENDP 0001034272 KIMMEL ROGER H C/O ROTHSCHILD INC. 1251 AVENUE OF THE AMERICAS NEW YORK NY 10022 1 0 0 0 Common Stock, par value, $.01 per share 2010-12-10 4 M 0 1250 11.00 A 193103 D Common Stock, par value, $.01 per share 2010-12-10 4 M 0 2500 11.05 A 195603 D Common Stock, par value, $.01 per share 2010-12-10 4 M 0 9991 20.42 A 205594 D Common Stock, par value, $.01 per share 2010-12-10 4 S 0 13741 36.55 D 191853 D 2000 Stock Incentive Plan Stock Options (NQ) 11.00 2010-12-10 4 M 0 1250 0.00 D 2012-03-12 Common Stock 1250 0 D 2000 Stock Incentive Plan Stock Options (NQ) 11.05 2010-12-10 4 M 0 2500 0.00 D 2013-03-12 Common Stock 2500 0 D 2000 Stock Incentive Plan Stock Options (NQ) 20.42 2010-12-10 4 M 0 9991 0.00 D 2014-03-12 Common Stock 9991 0 D This represents the average price at which Mr. Kimmel's common shares were sold at on December 10, 2010. This number represents (i) 165,000 shares of common stock held in trusts for which Mr. Kimmel serves as trustee and as to which shares Mr. Kimmel holds either the sole or the shared power of disposition and power to vote, (ii) 2,262 shares of restricted stock, all of which are fully vested, (iii) 9,593 restricted stock units, of which 4,750 are fully vested and (iv) 14,998 shares of common stock, receipt of which has been deferred under the Endo Pharmaceuticals Directors Deferred Compensation Plan. Mr. Kimmel's beneficial ownership disclosed in this table excludes all shares held by Mr. Kimmel indirectly, including shares underlying stock options as well as a total of 7,500 shares of common stock held in trusts for the benefit of Mr. Kimmel's adult children, as to which shares Mr. Kimmel has neither the power of disposition nor the power to vote. Mr. Kimmel's 5,000 non-qualified stock options granted under the 2000 Stock Incentive Plan on March 12, 2002, were generally exercisable 25% per year on each of March 12, 2003, March 12, 2004, March 12, 2005 and March 12, 2006. Mr. Kimmel's 5,000 non-qualified stock options granted under the 2000 Stock Incentive Plan on March 12, 2003, were generally exercisable 25% per year on each of March 12, 2004, March 12, 2005, March 12, 2006 and March 12, 2007. Mr. Kimmel's 10,000 non-qualified stock options granted under the 2000 Stock Incentive Plan on March 12, 2004, were generally exercisable 25% per year on each of March 12, 2005, March 12, 2006, March 12, 2007 and March 12, 2008. /s/ Caroline B. Manogue, by Power of Attorney 2010-12-13 EX-24.4_354713 2 poa.txt POA DOCUMENT LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS Know all by these present that the undersigned hereby makes, constitutes and appoints Caroline B. Manogue and Daniel Rudio as the undersigned's true and lawful attorneys-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of each of the undersigned to: (1) prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5 (including any amendments thereto) with respect to the securities of Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the "Company"), with the United States Securities and Exchange Commission, any national securities exchanges and the Company, as considered necessary or advisable under Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as amended from time to time (the "Exchange Act"); (2) seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information; and (3) perform any and all other acts which in the discretion of such attorney-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing. The undersigned acknowledges that: (1) this Power of Attorney authorizes, but does not require, such attorney-in-fact to act in their discretion on information provided to such attorney-in-fact without independent verification of such information; (2) any documents prepared and/or executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable; (3) neither the Company nor such attorney-in-fact assumes (i) any liability for the undersigned's responsibility to comply with the requirement of the Exchange Act, (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and (4) this Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act. The undersigned hereby gives and grants the foregoing attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, hereby ratifying all that such attorney-in-fact of, for and on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney. This Power of Attorney shall remain in full force and effect with respect to each undersigned until revoked by such undersigned in a signed writing delivered to such attorney-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 28th day of April 2009. SIGNATURE TITLE /s/ Roger H. Kimmel Director Roger H. Kimmel STATE OF PENNSYLVANIA: COUNTY OF DELAWARE: On this 28th day of April 2009, the above-named individual personally appeared before me, and acknowledged that he executed the foregoing instrument for the purposes therein contained. IN WITNESS WHEREOF, I have hereunto set my hand and official seal. /s/ Susan E. Dear Notary Public Commonwealth of Pennsylvania NOTARIAL SEAL Susan E. Dear, Notary Public Bethel Twp., Delaware County My Commission Expires January 8, 2013 -----END PRIVACY-ENHANCED MESSAGE-----